Parexel Industry Insights
-
3 Strategies For Articulating A Coherent Product Value Story
9/3/2024
These strategies are designed to help you navigate the intricate landscape of product development, ensuring that your innovation not only reaches the market but also achieves sustainable success in a competitive environment.
-
Are You Ready For The Coming Wave Of Regulatory Compliance?
9/3/2024
The COVID-19 pandemic exposed critical vulnerabilities in medical product supply chains, highlighting the need for robust regulatory compliance. Prepare your facility for future regulatory scrutiny by strengthening your compliance and quality management practices.
-
Lessons From China And The United States On The Use Of RWE In Regulatory Submissions
9/3/2024
Read along as authors share their most significant lessons, offering guidance on how to harness the full potential of RWE to drive innovation and efficiency in drug development.
-
Are You Using Real-World Evidence?
9/3/2024
This series of case studies illustrates how Real-World Evidence (RWE) can significantly enhance decision-making processes, leading to more efficient development strategies that save both time and costs.
-
Oncology Trials: Why The Patient Perspective Is Essential To Success
8/22/2024
By adopting a patient-guided approach, sponsors and CROs can focus on achieving outcomes that resonate most with the patients they aim to help, ensuring that the therapies developed are both effective and meaningful.
-
How Sponsors Can Make It Easier For Rare Disease Patients And Families To Participate In Trials
8/22/2024
New research highlights several significant challenges sponsors encounter when conducting clinical trials in rare neurological disorders.
-
Early-Phase Development Strategies For Navigating Regulatory Complexity In The EU
8/22/2024
Discover how to navigate EU regulatory challenges and position your clinical development program for long-term success by reading our latest insights.
-
Linking RWD And Patient Insights To Help Demonstrate Asset Value
8/22/2024
Real-world data (RWD) in clinical research often lacks detail on patients' personal characteristics and treatment experiences. In this example, our team leveraged innovative data science techniques to bridge the gap.
-
New Medicines, Novel Insights: Advancing Rare Disease Development
7/25/2024
This interactive report features insights from Parexel experts dedicated to patient-focused drug development, striving to expedite the market arrival of more rare disease treatments.
-
New Medicines, Novel Insights: Accelerating Development Of CAGT
7/25/2024
Cell and gene therapies hold tremendous promise for patients with advanced cancers and genetic diseases. Here, experts provide insights designed to accelerate development and market entry.